Overview

Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment

Status:
Terminated
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
This study is designed to investigate the efficacy and safety of rivastigmine compared with placebo in patients with mild cognitive impairment (MCI).
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Rivastigmine